SCHEMBL7467362

SCHEMBL7467362

[c]1ccc2c(c1)ccc1[nH]ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 8/20 0.34
PARP1 P09874 1/20 0.33
IMPDH2 P12268 1/20 0.32
IMPDH1 P20839 1/20 0.32
NR4A2 P43354 2/20 0.31
CYP2A6 P11509 1/20 0.31
CMA1 P23946 1/20 0.31
F7 P08709 1/20 0.31
LTA4H P09960 1/20 0.31
F3 P13726 1/20 0.31
TYR P14679 1/20 0.31
USP2 O75604 1/20 0.31
GAA P10253 1/20 0.31
ALOX15 P16050 1/20 0.31
RAD51 Q06609 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TRPA1 O75762 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
ITGB2 P05107 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70608 0.78 ALDH1A1 (0.33) CYP2A6
SCHEMBL2282037 0.74 HPRT1 (0.39) CYP2A6
Water SCHEMBL3636507 0.74 ALDH1A1 (0.52) AHRPARP1CYP2A6TRPA1CA1
SCHEMBL2398840 0.73 AHR (0.52) AHRPARP1NR4A2CYP2A6F7
SCHEMBL23566 0.73
Water SCHEMBL10356865 0.72 ALDH1A1 (0.50) AHRPARP1CYP2A6TRPA1CA1
Water SCHEMBL10356869 0.72 ALDH1A1 (0.50) AHRPARP1CYP2A6TRPA1CA1
Water SCHEMBL10356864 0.72 ALDH1A1 (0.50) AHRPARP1CYP2A6TRPA1CA1
SCHEMBL20424853 0.71 AHR (0.44) AHRIMPDH2IMPDH1NR4A2CYP2A6
SCHEMBL280428 0.71 ALDH1A1 (0.55) AHRPARP1CYP2A6TRPA1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703221-B1 5 alpha-reductase Inhibitors LILLY CO ELI (US) 2002-03-27 EP disclosed
US-6150375-A INHIBITORS OF BOTH OF THE HUMAN 5AR ISOZYMES; BENIGN PROSTATE HYPERPLASIA, MALE PATTERN BALDNESS, ACNE VULGARIS, SEBORRHEA, ANDROGENIC ALOPECIA, HIRSUTISM AND PROSTATE CANCER; BLOCKS THE CONVERSION OF TESTOSTERONE TO 5-ALPHA-DIHYDROTESTOSTERONE ELI LILLY AND COMPANY (US) 2000-11-21 US disclosed
US-5635197-A BENZO(F)QUINOLIN-3-ONES; ANTICARCINOGENIC AGENTS; BONE DISORDERS ELI LILLY AND COMPANY (US) 1997-06-03 US disclosed
US-5629007-A USING BENZOQUINOLIN-3-ONE DERIVATIVES ELI LILLY AND COMPANY (US) 1997-05-13 US disclosed
US-5622961-A PROSTATE CANCER, SKIN DISORDERS, BALDNESS ELI LILLY AND COMPANY (US) 1997-04-22 US disclosed
US-5622962-A PROSTATE CANCER, SKIN DISORDERS, BALDNESS ELI LILLY AND COMPANY (US) 1997-04-22 US disclosed
US-5578724-A INHIBITORS OF 5-ALPHA-REDUCTASE ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0742010-A2 Benzoquinolin-3-ones to inhibit bone loss ELI LILLY AND COMPANY (US) 1996-11-13 EP disclosed
EP-0733365-A2 Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed
WO-1996009046-A1 5α-REDUCTASE INHIBITORS ELI LILLY AND COMPANY (US) 1996-03-28 WO disclosed
EP-0703221-A1 5 alpha-reductase Inhibitors ELI LILLY AND COMPANY (US) 1996-03-27 EP disclosed